Medical Writing Authors Anuradha Alahari

Anuradha Alahari
Associate Editor / Section Editor

anuradha-alaharijpg

Medical writer with more than 10 years of experience in scientific and regulatory writing. Previous extensive experience in academic research in India, US, and France. Currently, Senior Medical Writer at Parexel International (https://www.parexel.com), located in France.


LinkedIn: www.linkedin.com/in/anuradhaalahari


Google Scholar: https://scholar.google.com/citations?user=efRprygAAAAJ&hl=en&oi=ao

                                                     anuradha.alahari@parexel.com 

Contributions

News from the EMA - Volume 32, Issue 4

Section Editor: Anuradha Alahari Medical Writing. 2023;32(4):64–68. https://doi.org/10.56012/oknc4756

News from the EMA - Volume 32, Issue 3

Anuradha Alahari (section editor)   EMA recommends revocation of authorisation for sickle cell disease medicine Adakveo OPEN framework extended to a wider range of medicines Global regulators agree on way forward to adapt COVID-19 vaccines to…

News from the EMA - Volume 32, Issue 2

This section offers a selection from recent news items from the EMA. Medical Writing. 2023;32(2)86–91.

News from the EMA - Volume 32, Issue 1

This roundup of news from the EMA includes information on vaccines to protect against dengue, therapy to treat transplant patients with post-transplant lymphoproliferative disease, the withdrawal of marketing authorisations for amfepramone…

News from the EMA - Volume 31, Issue 4

Medical Writing. 2022;31(4)65-69. Section editor: Anuradha Alahari

News from the EMA - Volume 31, Issue 3

News from the EMA - Volume 31, Issue 2

The articles included in this section are a selection from the European Medicines Agency (EMA)’s News and Press Releases archive. More information can be found on the Agency’s website: www.ema.europa.eu. Anuradha Alahari (editor)

News from the EMA - Volume 31, Issue 1

EMA is putting in place special support to developers to replace, reduce and refine animal use for the development, manufacturing and testing of human and veterinary medicines. The Agency is promoting these three principles replace, reduce and…

News from the EMA - Volume 30, Issue 4

Zynteglo is a one-time treatment for a blood disorder known as beta thalassaemia in patients 12 years and older who require regular blood transfusions. It is a gene therapy that uses a viral vector (or modified virus) to deliver a working gene into…

News from the EMA - Volume 30, Issue 3

Medical writers at EMA have published an “EMA medical terms simplifier” (https://www.ema.europa.eu/en/documents/ot her/ema-medical-terms-simplifier_ en.pdf) on the “Glossaries” page of EMA’s website (under “About us”) to provide public-friendly…

News from the EMA - Volume 30, Issue 2

February 26, 2021 – EMA has recommended granting a marketing authorisation in the European Union (EU) for the first treatment that can be given orally to patients with certain types of spinal muscular atrophy (SMA), a rare and often fatal genetic…

News from the EMA - Volume 29, Issue 4

September 14, 2020 – The Big Data Steering Group set up by EMA and the Heads of Medicines Agencies (HMA) has published its workplan which sets actions to be delivered in 2020–2021. With the European Medicines Regulatory Network focused on the…

News from the EMA - Volume 29, Issue 3

The articles included in this section are a selection from the European Medicines Agency (EMA)’s News and Press Releases archive. More information can be found on the Agency’s website: www.ema.europa.eu.

News from the EMA - Volume 29, Issue 2

The articles included in this section are a selection from the European Medicines Agency (EMA)’s News and Press Releases archive. More information can be found on the Agency’s website: www.ema.europa.eu

News from the EMA - Volume 29, Issue 1

The articles included in this section are an edited selection from the European Medicines Agency (EMA)’s News and Press Releases archive from October 2019 to December 2019. More information can be found on the Agency’s website: www.ema.europa.eu

News from the EMA - Volume 28, Issue 4

The articles included in this section are a selection from the European Medicines Agency (EMA)’s News and Press Releases archive from July 2019 to September 2019. More information can be found on the Agency’s website: www.ema.europa.eu.

News from the EMA - Volume 28, Issue 3

The articles included in this section are a selection from the European Medicines Agency (EMA)’s News and Press Releases archive from April 2019 to June 2019. More information can be found on the Agency’s website: www.ema.europa.eu

News from the EMA - Volume 28, Issue 2

The articles included in this section are a selection from the European Medicines Agency (EMA)’s News and Press Releases archive from January 2019 to March 2019. More information can be found on the Agency’s website: www.ema.europa.eu

News from the EMA - Volume 28, Issue 1

October 5, 2018 and November 16, 2018 – Fluoroquinolones and quinolones are a class of broad-spectrum antibiotics that are active against bacteria of both Gram-negative and Grampositive classes. EMA’s Pharmacovigilance Risk Assessment Committee…

News from the EMA - Volume 27, Issue 4

The articles included in this section are a selection from the European Medicines Agency’s News and Press Release archive from July 2018 to September 2018. More information can be found on the agency’s website: www.ema.europa.eu

News from the EMA - Volume 27, Issue 3

April 12, 2018 – The European Medicines Agency's (EMA) and its European and international partners have successfully strengthened their interactions to improve the oversight of active pharmaceutical ingredient (API) manufacturers worldwide, as…

News from the EMA - Volume 27, Issue 2

The articles included in this section are a selection from the European Medicines Agency’s News and Press Release archive from January 2018 to March 2018. More information can be found on the agency’s website: www.ema.europa.eu

News from the EMA - Volume 27, Issue 1

The articles included in this section are a selection from the European Medicines Agency’s News and Press Release archive from October 2017 to December 2017. More information can be found on the Agency’s website: http://www.ema.europa.eu/

News from the EMA - Volume 26, Issue 4

The articles included in this section are a selection from the European Medicines Agency’s News and Press Release archive from July 2017 to September 2017. More information can be found on the Agency’s website: www.ema.europa.eu

News from the EMA - Volume 26, Issue 3

April, 6, 2017 – Following two years of experience with safety monitoring of nationally authorised medicines via the single assessment of periodic safety update reports (PSURs), the EMA has issued additional guidance and recommendations as part of…

News from the EMA - Volume 26, Issue 2

Conditional marketing authorisations give patients access to important new medicines earlier January 23, 2017 – Conditional marketing authorisation (CMA) can speed up access to medicines for patients with unmet medical needs in the European Union…

News from the EMA - Volume 26, Issue 1

November 15, 2016 — The EMA, in cooperation with the European Commission and the Member States of the EU, is proposing changes to its existing guideline on first-in-human clinical trials, to further improve the safety of trial participants. The…

News from the EMA - Volume 25, Issue 4

The articles included in this section are a selection from the European Medicines Agency’s News and Press Release archive for August 2016 – Oct 2016. More information can be found on the Agency’s website: www.ema.europa.eu of medicines to treat…

News from the EMA - Volume 25, Issue 3

The articles included in this section are a selection from the European Medicines Agency’s news and press release archive for April 2016 to July 2016.

News from the EMA - Volume 25, Issue 2

The articles included in this section are a selection from the European Medicines Agency’s news and press release archive for November 2015 to March 2016.

Search

Member Login

Links

The Write Stuff Archive Contact Instructions for Authors Article Template (Word) Journal Policies

Scope

Medical Writing is a quarterly publication that aims to educate and inform medical writers in Europe and beyond. Each issue focuses on a specific theme, and all issues include feature articles and regular columns on topics relevant to the practice of medical writing. We welcome articles providing practical advice to medical writers; guidelines and reviews/summaries/updates of guidelines published elsewhere; original research; opinion pieces; interviews; and review articles.

Medical Writing is listed in the following indexes:

Editoral Board

Editor-in-Chief

Raquel Billiones

Co-Editors

Evguenia Alechine

Jonathan Pitt

Managing Editor

Victoria White

Associate Editors

Anuradha Alahari

Jennifer Bell

Nicole Bezuidenhout

Claire Chang

Barbara Grossman

Sarah Milner

John Plant

Sampoorna Rappaz

Amy Whereat

Section Editors

Daniela Kamir

AI/Automation

Jennifer Bell

Biotechnology

Nicole Bezuidenhout 

Digital Communication

Somsuvro Basu

EMWA News 

Ana Sofia Correia 

Gained in Translation

Ivana Turek

Getting Your Foot in the Door

Wendy Kingdom / Amy Whereat

Good Writing Practice

Alison McIntosh 

In the Bookstores

Maria Kołtowska-Häggström

Lingua Franca and Beyond

Maddy Dyer

Publications

Lisa Chamberlain-James

Medical Communications/Writing for Patients

Payal Bhatia

Medical Devices

Evguenia Alechine

My First Medical Writing

Anuradha Alahari

News from the EMA

Adriana Rocha

Out on Our Own

Tiziana von Bruchhausen

Pharmacovigilance

Clare ChangZuo Yen Lee 

Regulatory Matters

Sam Hamilton

Regulatory Public Disclosure

Claire Gudex

Teaching Medical Writing

Louisa Ludwig-Begall / Sarah Kabani

The Crofter: Sustainable Communications

Louisa Marcombes

Veterinary Writing

Editors Emeritus

Elise Langdon-Neuner

Phil Leventhal

Layout Designer

Chris Monk